Canadian cannabis company Aurora Cannabis has secured a US patent for its groundbreaking research on auto-flowering technology in cannabis. This innovation could revolutionize cannabis cultivation, particularly in high-latitude regions, by allowing plants to automatically transition to the flowering stage, independent of light cycles. Aurora’s research also focuses on improving potency, yield, and overall efficiency in cannabis production.
Jones Soda Co. is expanding its Mary Jones cannabis brand with the launch of HD9 Cola and Zero Cola, bringing the world’s most popular soft drink flavor to the THC-infused beverage market. The new colas are made with unique formulas designed to deliver a crisp, refreshing taste with no weedy aftertaste.
South Africa’s ambitious plan to establish a thriving cannabis and hemp industry faces challenges, particularly for small-scale farmers. While the government has issued permits and implemented support initiatives, the legal landscape remains complex, impacting the livelihoods of traditional cultivators.
With inflation at its lowest level since 2021, the cannabis industry is set to benefit from potential interest rate cuts. Lower borrowing costs, easier access to financing, increased investor interest, opportunities for expansion, and stronger consumer spending are all key factors that could drive growth in the cannabis sector.
A new study suggests the Czech Republic could be leaving millions of euros on the table by delaying the legalization of cannabis. Researchers have calculated that a fully regulated market could generate significant economic benefits, surpassing the current prohibitionist approach.
New Lake Capital Partners (NLCP) emerges as a stable investment choice within the volatile cannabis market, offering consistent returns through its real estate portfolio. NLCP boasts strong dividend yields, robust rental income growth, and a conservative debt strategy, making it an attractive option for investors navigating the turbulent landscape of the cannabis industry.
A new study suggests that high-CBD vaginal suppositories may be an effective treatment for menstrual discomfort. Researchers found that participants using the suppositories experienced reduced pain, improved mood, and decreased reliance on pain medication. The study highlights the potential of cannabinoid-based therapies for managing menstrual symptoms.
InterCure Ltd. (INCR) has demonstrated resilience in its first half of 2024 performance despite facing significant challenges, including disruptions at its southern Israeli facility. The company exceeded revenue estimates but continues to experience growth limitations due to the ongoing conflict. InterCure is investing heavily in restoring its facility and expects to return to full operational capacity in the coming quarters, aiming for double-digit sales growth in the second half of 2024.
The potential reclassification of marijuana from a Schedule I to a Schedule III drug could significantly impact the pre-roll industry. This article explores the potential benefits of reclassification, including reduced tax burdens, increased access to banking, and opportunities for research and development. It also highlights the importance of preparing for increased competition and strategizing for future success.
Japan is taking a two-pronged approach to cannabis, criminalizing personal use while simultaneously legalizing medical cannabis products. The move aims to regulate cannabis use, combat drug abuse, and expand access to cannabis-derived medicines.
